| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
146,000,000 |
| Market
Cap: |
15.86(B) |
| Last
Volume: |
1,605,892 |
Avg
Vol: |
1,353,529 |
| 52
Week Range: |
$92.79 - $209.935 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 11.4 |
| Insider 3/6 Months : 12 |
|
| Guru Rank Number : 691 |
| Guru Rank Value : 2.3 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
7,330 |
7,330 |
7,330 |
| Total Buy Value |
$0 |
$991,672 |
$991,672 |
$991,672 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
1,815 |
22,740 |
| Total Sell Value |
$0 |
$0 |
$314,105 |
$4,648,975 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
4 |
17 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Epstein Robert S |
Director |
• • – |
2018-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,473 |
7,139 |
|
- |
|
| Schiller Philip W |
Director |
• • – |
2018-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,473 |
7,787 |
|
- |
|
| Eastham Karin |
Director |
• • – |
2018-05-22 |
4 |
D |
$270.80 |
$249,678 |
D/D |
(922) |
11,366 |
|
- |
|
| Dorsa Caroline |
Director |
• • – |
2018-05-22 |
4 |
D |
$270.80 |
$249,678 |
D/D |
(922) |
6,379 |
|
- |
|
| Epstein Robert S |
Director |
• • – |
2018-05-22 |
4 |
D |
$270.80 |
$249,678 |
D/D |
(922) |
5,666 |
|
- |
|
| Schiller Philip W |
Director |
• • – |
2018-05-22 |
4 |
D |
$270.80 |
$249,678 |
D/D |
(922) |
6,314 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2018-05-22 |
4 |
D |
$270.80 |
$249,678 |
D/D |
(922) |
15,946 |
|
- |
|
| Eastham Karin |
Director |
• • – |
2018-05-21 |
4 |
AS |
$268.01 |
$269,802 |
D/D |
(1,000) |
12,288 |
|
- |
|
| Epstein Robert S |
Director |
• • – |
2018-05-21 |
4 |
AS |
$271.00 |
$135,500 |
D/D |
(500) |
6,588 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-05-16 |
4 |
AS |
$267.71 |
$2,677,135 |
D/D |
(10,000) |
70,996 |
|
- |
|
| Ronaghi Mostafa |
Sr VP & CTO |
• • – |
2018-05-16 |
4 |
OE |
$28.45 |
$284,500 |
D/D |
10,000 |
80,996 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2018-05-14 |
4 |
S |
$268.00 |
$391,280 |
I/I |
(1,460) |
4,000 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2018-05-14 |
4 |
AS |
$267.41 |
$564,124 |
D/D |
(2,100) |
86,471 |
|
- |
|
| Ostadan Omead |
EVP Ops, Products, Strategy |
• • – |
2018-05-02 |
4 |
AS |
$242.60 |
$318,776 |
D/D |
(1,314) |
27,153 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2018-05-01 |
4 |
AS |
$240.90 |
$724,336 |
D/D |
(3,000) |
16,868 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2018-05-01 |
4 |
OE |
$44.51 |
$165,426 |
D/D |
3,000 |
19,868 |
|
- |
|
| Van Oene Mark |
SVP Chief Commercial Officer |
• • – |
2018-04-12 |
4 |
AS |
$238.48 |
$333,872 |
D/D |
(1,400) |
12,217 |
|
- |
|
| Dadswell Charles |
Sr VP & General Counsel |
• • – |
2018-04-03 |
4 |
AS |
$230.91 |
$26,786 |
D/D |
(116) |
7,875 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2018-04-02 |
4 |
AS |
$226.92 |
$690,383 |
D/D |
(3,000) |
16,868 |
|
- |
|
| Bowman A Blaine |
Director |
• • – |
2018-04-02 |
4 |
OE |
$44.51 |
$133,530 |
D/D |
3,000 |
19,868 |
|
- |
|
| Arnold Frances |
Director |
• • – |
2018-03-15 |
4 |
AS |
$252.26 |
$63,065 |
D/D |
(250) |
10,189 |
|
- |
|
| Arnold Frances |
Director |
• • – |
2018-03-08 |
4 |
AS |
$241.50 |
$60,375 |
D/D |
(250) |
10,439 |
|
- |
|
| Stapley Marc |
EVP Strategy & Corp Developmt |
• • – |
2018-03-06 |
4 |
AS |
$231.12 |
$467,288 |
D/D |
(2,000) |
13,787 |
|
- |
|
| Eastham Karin |
Director |
• • – |
2018-03-05 |
4 |
AS |
$226.80 |
$458,735 |
D/D |
(2,000) |
13,288 |
|
- |
|
| Eastham Karin |
Director |
• • – |
2018-03-05 |
4 |
OE |
$71.09 |
$142,180 |
D/D |
2,000 |
15,288 |
|
- |
|
1655 Records found
|
|
Page 27 of 67 |
|
|
0.56 (0.51%) 
